183 related articles for article (PubMed ID: 29278339)
41. The provisional ACR/EULAR definition of remission in RA: a comment on the patient global assessment criterion.
Vermeer M; Kuper HH; van der Bijl AE; Baan H; Posthumus MD; Brus HL; van Riel PL; van de Laar MA
Rheumatology (Oxford); 2012 Jun; 51(6):1076-80. PubMed ID: 22302059
[TBL] [Abstract][Full Text] [Related]
42. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
Tugwell P; Wells G; Strand V; Maetzel A; Bombardier C; Crawford B; Dorrier C; Thompson A
Arthritis Rheum; 2000 Mar; 43(3):506-14. PubMed ID: 10728742
[TBL] [Abstract][Full Text] [Related]
43. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
El Miedany Y; Youssef SS; El Gaafary M
J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
[TBL] [Abstract][Full Text] [Related]
44. Effects of fostamatinib (R788), an oral spleen tyrosine kinase inhibitor, on health-related quality of life in patients with active rheumatoid arthritis: analyses of patient-reported outcomes from a randomized, double-blind, placebo-controlled trial.
Weinblatt ME; Kavanaugh A; Genovese MC; Jones DA; Musser TK; Grossbard EB; Magilavy DB
J Rheumatol; 2013 Apr; 40(4):369-78. PubMed ID: 23378467
[TBL] [Abstract][Full Text] [Related]
45. Doxycycline in the treatment of rheumatoid arthritis--a pilot study.
Sreekanth VR; Handa R; Wali JP; Aggarwal P; Dwivedi SN
J Assoc Physicians India; 2000 Aug; 48(8):804-7. PubMed ID: 11273473
[TBL] [Abstract][Full Text] [Related]
46. [Efficacy and safety of infliximab in patients with rheumatoid arthritis].
Zhang W; Shi Q; Wu DH; Bao CD; Yang NP; Li ZG; Zhu P; Zhang X; Huang CB; He DY; Ye ZZ; Tao Y; Fang YF; Gu JR; Wu HX; Sun LY; Yang XY; Huang F; Xu HJ; Zhao DB; Zhang MJ; Zheng Y; Ai MX; Lu J; Zhang FC
Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(27):1876-80. PubMed ID: 19953907
[TBL] [Abstract][Full Text] [Related]
47. Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation.
Bingham CO; Gaich CL; DeLozier AM; Engstrom KD; Naegeli AN; de Bono S; Banerjee P; Taylor PC
Trials; 2019 Mar; 20(1):182. PubMed ID: 30902094
[TBL] [Abstract][Full Text] [Related]
48. Sources of discrepancy in patient and physician global assessments of rheumatoid arthritis disease activity.
Nicolau G; Yogui MM; Vallochi TL; Gianini RJ; Laurindo IM; Novaes GS
J Rheumatol; 2004 Jul; 31(7):1293-6. PubMed ID: 15229946
[TBL] [Abstract][Full Text] [Related]
49. Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON).
Smolen JS; Kremer JM; Gaich CL; DeLozier AM; Schlichting DE; Xie L; Stoykov I; Rooney T; Bird P; Sánchez Bursón JM; Genovese MC; Combe B
Ann Rheum Dis; 2017 Apr; 76(4):694-700. PubMed ID: 27799159
[TBL] [Abstract][Full Text] [Related]
50. Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region.
Machado DA; Guzman RM; Xavier RM; Simon JA; Mele L; Pedersen R; Ferdousi T; Koenig AS; Kotak S; Vlahos B
J Clin Rheumatol; 2014 Jan; 20(1):25-33. PubMed ID: 24356474
[TBL] [Abstract][Full Text] [Related]
51. The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate.
Scarpa R; Peluso R; Atteno M; Manguso F; Spanò A; Iervolino S; Di Minno MN; Costa L; Del Puente A
Clin Rheumatol; 2008 Jul; 27(7):823-6. PubMed ID: 18030515
[TBL] [Abstract][Full Text] [Related]
52. Good response to infliximab in rheumatoid arthritis following failure of interleukin-1 receptor antagonist.
Bao J; Yue T; Li T; He DY; Bao YX
Int J Rheum Dis; 2016 Apr; 19(4):370-6. PubMed ID: 24798350
[TBL] [Abstract][Full Text] [Related]
53. Discordance and accordance between patient's and physician's assessments in rheumatoid arthritis.
Furu M; Hashimoto M; Ito H; Fujii T; Terao C; Yamakawa N; Yoshitomi H; Ogino H; Ishikawa M; Matsuda S; Mimori T
Scand J Rheumatol; 2014; 43(4):291-5. PubMed ID: 24650255
[TBL] [Abstract][Full Text] [Related]
54. Effectiveness and safety of infliximab in rheumatoid arthritis: analysis from a Canadian multicenter prospective observational registry.
Thorne C; Bensen WG; Choquette D; Chow A; Khraishi M; Atkins CJ; Kelsall JT; Lehman AJ; Shawi M; Khalil H; Nantel F; Rampakakis E; Sampalis JS; Otawa S
Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1142-51. PubMed ID: 24470077
[TBL] [Abstract][Full Text] [Related]
55. Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials.
Tanaka Y; Atsumi T; Amano K; Harigai M; Ishii T; Kawaguchi O; Rooney TP; Akashi N; Takeuchi T
Mod Rheumatol; 2018 Jul; 28(4):583-591. PubMed ID: 29134891
[TBL] [Abstract][Full Text] [Related]
56. Pain Catastrophizing, Subjective Outcomes, and Inflammatory Assessments Including Ultrasound: Results From a Longitudinal Study of Rheumatoid Arthritis Patients.
Hammer HB; Uhlig T; Kvien TK; Lampa J
Arthritis Care Res (Hoboken); 2018 May; 70(5):703-712. PubMed ID: 28805018
[TBL] [Abstract][Full Text] [Related]
57. New Rheumatoid Arthritis Treatments for 'Old' Patients: Results of a Systematic Review.
Caporali R; Fakhouri WKH; Nicolay C; Longley HJ; Losi S; Rogai V
Adv Ther; 2020 Sep; 37(9):3676-3691. PubMed ID: 32705531
[TBL] [Abstract][Full Text] [Related]
58. Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission after Six Months of Non-tumor Necrosis Factor Biological Disease-Modifying Antirheumatic Drugs (DMARDs) Treatment.
Miwa Y; Saito M; Furuya H; Yanai R; Ikari Y; Hayashi T; Kasama T; Toyoshima Y; Inagaki K
Intern Med; 2017 Sep; 56(17):2271-2275. PubMed ID: 28794381
[TBL] [Abstract][Full Text] [Related]
59. Physician global assessment at 3 months is strongly predictive of remission at 12 months in early rheumatoid arthritis: results from the CATCH cohort.
Choy T; Bykerk VP; Boire G; Haraoui BP; Hitchon C; Thorne C; Keystone EC; Pope JE;
Rheumatology (Oxford); 2014 Mar; 53(3):482-90. PubMed ID: 24241035
[TBL] [Abstract][Full Text] [Related]
60. Patient Global Assessment of Disease Activity and Radiographic Progression in Early Arthritis: Three-Year Results From the ESPOIR Cohort.
Ferreira RJO; Fautrel B; Saraux A; Gaujoux-Viala C; Rat AC; Guillemin F; da Silva JAP; Dougados M; Gossec L
Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1300-1305. PubMed ID: 32339449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
